STOCK TITAN

Astrana Health (ASTH) director awarded 41,667 RSUs with multi-year vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lam Thomas S. reported acquisition or exercise transactions in this Form 4 filing.

Astrana Health, Inc. director Thomas S. Lam received an equity award of 41,667 restricted stock units (RSUs) of common stock on April 6, 2026. The RSUs carry no purchase price and represent a compensation grant, not an open-market share purchase.

Each RSU is a contingent right to one Astrana common share. The award will vest in eight equal semi-annual installments beginning on October 6, 2026, provided Lam remains employed with Astrana Health and/or its affiliates. After this grant, he directly holds 465,657 shares of common stock, including other previously granted restricted stock and RSUs subject to multi-year vesting schedules.

Separate from his direct holdings, Lam is reported as having indirect interests in 6,132,802 shares held by Allied Physicians of California, a Professional Medical Corporation, where he serves as CEO, CFO, director and stockholder, and 1,133,706 shares held by the Thomas and Jeanette Lam 2002 Family Trust. He disclaims beneficial ownership of the Allied Physicians shares except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Lam Thomas S.
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 41,667 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 465,657 shares (Direct); Common Stock — 6,132,802 shares (Indirect, By Allied Physicians of California, a Professional Medical Corporation)
Footnotes (1)
  1. These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 41,667 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates).
RSU grant size 41,667 RSUs Grant to Thomas S. Lam on April 6, 2026
RSU grant price $0.0000 per share Equity award, not open-market purchase
Direct holdings after grant 465,657 shares Common stock directly held by Lam post-transaction
Indirect Allied Physicians holdings 6,132,802 shares Held by Allied Physicians of California; Lam disclaims full beneficial ownership
Indirect family trust holdings 1,133,706 shares Held by Thomas and Jeanette Lam 2002 Family Trust
Additional unvested restricted stock 51,667 shares Vests in two equal annual installments beginning March 5, 2027
Additional unvested restricted stock 13,334 shares Vests in two equal annual installments beginning April 1, 2027
restricted stock units financial
"Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
semi-annual installments financial
"the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026"
restricted stock financial
"Includes the following shares of restricted stock, which will vest as follows"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lam Thomas S.

(Last)(First)(Middle)
C/O ASTRANA HEALTH, INC.
1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)
ALHAMBRA CALIFORNIA 91801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/06/2026A41,667(2)A$0465,657(3)D
Common Stock6,132,802IBy Allied Physicians of California, a Professional Medical Corporation(1)
Common Stock1,133,706IBy the Thomas and Jeanette Lam 2002 Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026.
3. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 41,667 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates).
/s/ Thomas S. Lam04/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Astrana Health (ASTH) director Thomas S. Lam receive in this Form 4?

Thomas S. Lam received a grant of 41,667 restricted stock units of Astrana Health common stock as compensation. Each unit converts into one share if vesting conditions are met, rather than being purchased in the open market.

How do the 41,667 RSUs for ASTH vest for Thomas S. Lam?

The 41,667 restricted stock units vest in eight equal semi-annual installments starting October 6, 2026. Vesting requires Lam to remain continuously employed with Astrana Health or its affiliates through each vesting date under the award’s terms.

What are Thomas S. Lam’s direct ASTH share holdings after this grant?

After the RSU grant, Lam directly holds 465,657 shares of Astrana Health common stock. This figure includes existing restricted stock and restricted stock units that will vest over time, assuming he maintains continuous employment with the company or its affiliates.

What indirect Astrana Health (ASTH) holdings are associated with Thomas S. Lam?

Indirectly, 6,132,802 shares are held by Allied Physicians of California and 1,133,706 shares by the Thomas and Jeanette Lam 2002 Family Trust. The Form 4 notes Lam’s roles and that he disclaims beneficial ownership of the Allied Physicians shares except for his pecuniary interest.

Is this ASTH Form 4 a stock purchase or a compensation award?

This Form 4 reflects a compensation award, not a market purchase. Lam received 41,667 restricted stock units at no purchase price, recorded under transaction code A for a grant or award, with future vesting based on continued employment.